Portfolio company
Talus Bioscience
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops an AI-enabled drug discovery platform and small-molecule therapeutics for pharmaceutical and biotechnology organisations to target transcription factors.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Talus Bio
The company develops a drug discovery platform that identifies transcription factor modulators for pharmaceutical and biotechnology partners seeking to treat cancers and other diseases.
Tessel Biosciences
The company develops artificial intelligence models and patient-derived virtual tissues to accelerate drug discovery for pharmaceutical and biotechnology organisations.
Cime Therapeutics
The company develops an automated drug discovery platform using synthetic chemistry and artificial intelligence to create therapeutic molecules for pharmaceutical organisations.
Atomic AI
This company develops artificial intelligence platforms for RNA-targeted drug discovery to assist biotechnology and pharmaceutical organisations with medicine development.
Ten63 Therapeutics
This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.
Auron Therapeutics
This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.
Celeris Therapeutics
The company develops artificial intelligence software to design and discover protein degrader drugs for pharmaceutical and biotechnology organisations.
Aqemia
This company develops a drug discovery platform using physics-based algorithms and artificial intelligence for pharmaceutical and biotechnology organisations.
